8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Jan 27, 2005)

Filed January 27, 2005For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on January 27, 2005, to report its financial results for the quarter and full year ended December 31, 2004. The report primarily serves to incorporate by reference a press release detailing these results. Investors should refer to the press release (Exhibit 99.1) for specific financial figures and performance commentary. While the 8-K itself does not contain the detailed financial data, it signals the official release of Quest Diagnostics' fourth-quarter and year-end 2004 performance. The Chief Financial Officer, Robert A. Hagemann, signed off on the filing, indicating the information's official status. Investors seeking a comprehensive understanding of the company's financial health and strategic outlook for 2004 would need to access the referenced press release for quantitative metrics and qualitative analysis.

Key Highlights

  • 1Quest Diagnostics filed an 8-K on January 27, 2005, reporting Q4 and full-year 2004 financial results.
  • 2The primary purpose of the 8-K was to furnish a press release announcing these results.
  • 3The press release, attached as Exhibit 99.1, contains the detailed financial information.
  • 4The filing officially disseminates the company's financial performance for the period ended December 31, 2004.
  • 5Robert A. Hagemann, Senior Vice President and Chief Financial Officer, signed the report.
  • 6Investors are directed to Exhibit 99.1 for specific financial data and operational updates.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce and provide access to Quest Diagnostics' financial results for the fourth quarter and the full fiscal year ended December 31, 2004, through an accompanying press release.

The detailed financial results are contained in the press release issued by Quest Diagnostics on January 27, 2005, which is attached as Exhibit 99.1 to this 8-K filing and incorporated by reference.

Robert A. Hagemann is the Senior Vice President and Chief Financial Officer of Quest Diagnostics. His signature on the 8-K report signifies that the information being filed has been reviewed and authorized by the company's senior financial management.

No, the 8-K filing itself does not contain the specific financial numbers. It only states that a press release with these details has been issued and is attached as an exhibit.